New FDA guidance on general clinical trial conduct in the era of COVID-19

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J. C., Biondi‐Zoccai, G., Brown, T. S., Der-Nigoghossian, C. A., Zidar, D. A., Haythe, J. H., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,037 · see citing works

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

Wang, L., Wang, Y., Ye, D., & Liu, Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105948 · Cited by 1,200 · see citing works

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases

Ramanathan, K. R., Antognini, D. G., Combes, A., Paden, M. L., Zakhary, B., Ogino, M., MacLaren, G., Brodie, D., & Shekar, K. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30121-1 · Cited by 541 · see citing works

Adaptive design methods in clinical trials–a review

Chow, S.-C., & Chang, M. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-11 · Cited by 482 · see citing works

Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

Giudicessi, J. R., Noseworthy, P. A., Friedman, P. A., & Ackerman, M. J. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.03.024 · Cited by 394 · see citing works

Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade

Perico, L., Benigni, A., & Remuzzi, G. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000507305 · Cited by 305 · see citing works

COVID-19 Infection

Greenland, J. R., Michelow, M. D., Wang, L., & London, M. J. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003303 · Cited by 208 · see citing works

Adaptive Design Methods in Clinical Trials

Chow, S., & Pong, A. (2010) · Informa Healthcare eBooks · doi:10.3109/9781439822463.003 · Cited by 165 · see citing works

Adaptive Design Methods in Clinical Trials

Chow, S., & Chang, M. (2006) · Chapman & Hall/CRC eBooks · doi:10.1201/9781584887775 · Cited by 108 · see citing works

Global coronavirus disease 2019: What has daily cumulative index taught us?

Lai, C., Wang, C., Wang, Y., & Hsueh, P. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106001 · Cited by 20 · see citing works

Blood transfusion strategies and ECMO during the COVID-19 pandemic – Authors' reply

Ramanathan, K. R., MacLaren, G., Combes, A., Brodie, D., & Shekar, K. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30174-0 · Cited by 13 · see citing works

Limiting racial disparities and bias for wearable devices in health science research

Colvonen, P. J., DeYoung, P. N., Bosompra, N.-O. A., & Owens, R. L. (2020) · Sleep · doi:10.1093/sleep/zsaa159 · Cited by 137 · see citing works

Critical Bias in Critical Care Devices

Charpignon, M.-L., Byers, J., Cabral, S., Celi, L. A., Fernandes, C., Gallifant, J., Lough, M. E., Mlombwa, D., Moukheiber, L., Ong, B. A., et al. (2023) · Critical Care Clinics · doi:10.1016/j.ccc.2023.02.005 · Cited by 35 · see citing works

Randomized Controlled Trial of a Remote Coaching mHealth Adherence Intervention in Youth Living with HIV

Amico, K. R., Lindsey, J. C., Hudgens, M. G., Dallas, R. H., Horvath, K. J., Dunlap, A., Goolsby, R. W., Johnson, M. M., Heckman, B. E., Crawford, J., et al. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03717-2 · Cited by 27 · see citing works

Deep learning-based risk prediction for interventional clinical trials based on protocol design: A retrospective study

Ferdowsi, S., Knafou, J., Borissov, N., Alvarez, D. V., Mishra, R., Amini, P., & Teodoro, D. (2023) · Patterns · doi:10.1016/j.patter.2023.100689 · Cited by 19 · see citing works

Advancing Regulatory Oversight of Medical Device Trials to Align with Clinical Drug Standards in the European Union

Pannonhalmi, Á., Sipos, B., Kurucz, R. I., Katona, G., Kemény, L. V., & Csóka, I. (2025) · Pharmaceuticals · doi:10.3390/ph18060876 · Cited by 17 · see citing works

COVID-19 e os desafios para a regulação de medicamentos em tempos de pandemia

Pepe, V. L. E., Novaes, H. M. D., & Osorio-de-Castro, C. G. S. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-812320212610.11472021 · Cited by 10 · see citing works

Efficacy and Sustainability of Diabetes-Specific Meal Replacement on Obese and Overweight Type-2 Diabetes Mellitus Patients: Study Approaches for a Randomised Controlled Trial and Impact of COVID-19 on Trial Progress

Chen, L. L., Ludin, A. F. M., Shahar, S., Manaf, Z. A., & Tohit, N. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074188 · Cited by 9 · see citing works

Clinical Trials Before, During, and After COVID-19 Pandemic

AlSaleh, K. A. (2021) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000783 · Cited by 8 · see citing works

Classification of hierarchical text using geometric deep learning: the case of clinical trials corpus

Ferdowsi, S., Borissov, N., Knafou, J., Amini, P., & Teodoro, D. (2021) · Conference on Empirical Methods in Natural Language Processing (EMNLP) · doi:10.18653/v1/2021.emnlp-main.48 · Cited by 8 · see citing works

Digital-Focused Approaches in Cancer Patients’ Management in the Post-COVID Era: Challenges and Solutions

Georgescu, I., Dricu, A., Artene, S.-A., Vrăjitoru, N.-R., Barcan, E., Tache, D. E., Giubelan, L.-I., Staicu, G.-A., Manea (Carneluti), E.-V., Pană, C., et al. (2024) · Applied Sciences · doi:10.3390/app14188097 · Cited by 6 · see citing works

COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review

Vinutha, M., Sharma, U., Swamy, G., Rohini, S., Vada, S., Janandri, S., Haribabu, T. E., Taj, N., Gayathri, S. V., Jyotsna, S., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123022 · Cited by 6 · see citing works

The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience

Feinstein, A., Amato, M. P., Brichetto, G., Chataway, J., Chiaravalloti, N. D., Cutter, G., Dalgas, U., DeLuca, J., Farrell, R. A., Feys, P., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10881-3 · Cited by 5 · see citing works

Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?

Daizadeh, I. (2020) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-020-00233-0 · Cited by 5 · see citing works

Clinical trial visits in the age of COVID-19: implementation of research participant safety measures

Krueger, K. J., Rahman, F. K., Shen, Q., Hiebert, J. B., & Pierce, J. D. (2021) · International Journal of Clinical Trials · doi:10.18203/2349-3259.ijct20211466 · Cited by 5 · see citing works

Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence

Wang, Y., Daar, E. S., Huang, Y., Xiong, D., Shen, J., Zhou, L., Siqueiros, L., Guerrero, M., Rosen, M. I., & Liu, H. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04118-9 · Cited by 3 · see citing works

Trial characteristics, methods and reported challenges of decentralised clinical trials: a scoping review

Cussen, A., & Littler, K. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-106823 · Cited by 2 · see citing works

Do Funders, Regulators, and Ethics Bodies Support Informative Trials? A Content Analysis of Global Guidance Documents

Prowse, S. R., Brazzelli, M. G., Bruhn, H., & Treweek, S. (2026) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70356 · Cited by 2 · see citing works

Nobody dares stopping clinical research, not even COVID-19

Malfettone, A., Cosimo, S. D., Pérez-García, J. M., García, A. N., Sampayo-Cordero, M., Mina, L. B., Herrero, C., Llombart‐Cussac, A., & Cortés, J. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00249-1

Introduction to The Oxford Handbook of Personality and Psychopathology Assessment

Mihura, J. L. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190092689.013.1

Patient-Reported Outcome Measures in Acute Stroke Trials

Ali, M., Liang, H., & Nouh, A. M. (2026) · Neurology Open Access · doi:10.1212/wn9.0000000000000149

FDA Updates Highlighting the Latest Cancer Treatments

(2020) · Oncology Times · doi:10.1097/01.cot.0000661916.81050.c4

Coronavirus pandemic (COVID-19) - Clinical trials advice

Novara, D. (2020) · Clinical Research and Trials · doi:10.15761/crt.1000301

Realignment of clinical research after the COVID-19 era

Thomas, D., McDonald, V. M., & Gibson, P. G. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00080-8 · Cited by 3 · see citing works

Impact of corona virus (COVID-19) on Clinical trials and clinical research: A systematic reviewPreprint

Sathian, B. (2020) · OSF Preprints (OSF Preprints) · doi:10.17605/osf.io/njt8d

FDA Guidance for Clinical Trials During COVID-19 Pandemic

Slater, H. (2020)